CenterBook Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.8M | Buy |
+34,345
| New | +$26.8M | 1.49% | 10 |
|
|
2025
Q1 | – | Sell |
-19,306
| Closed | -$14.9M | – | 547 |
|
|
2024
Q4 | $14.9M | Buy |
19,306
+17,222
| +826% | +$13.3M | 0.89% | 17 |
|
|
2024
Q3 | $1.85M | Sell |
2,084
-6,629
| -76% | -$5.87M | 0.11% | 203 |
|
|
2024
Q2 | $7.89M | Buy |
8,713
+525
| +6% | +$475K | 0.49% | 49 |
|
|
2024
Q1 | $6.37M | Buy |
+8,188
| New | +$6.37M | 0.44% | 63 |
|
|
2023
Q4 | – | Sell |
-2,976
| Closed | -$1.6M | – | 448 |
|
|
2023
Q3 | $1.6M | Sell |
2,976
-832
| -22% | -$447K | 0.2% | 176 |
|
|
2023
Q2 | $1.79M | Sell |
3,808
-2,854
| -43% | -$1.34M | 0.22% | 162 |
|
|
2023
Q1 | $2.29M | Sell |
6,662
-1,117
| -14% | -$384K | 0.32% | 99 |
|
|
2022
Q4 | $2.85M | Buy |
7,779
+2,769
| +55% | +$1.01M | 0.47% | 50 |
|
|
2022
Q3 | $1.62M | Sell |
5,010
-1,777
| -26% | -$575K | 0.31% | 104 |
|
|
2022
Q2 | $2.2M | Buy |
+6,787
| New | +$2.2M | 0.47% | 52 |
|